BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $16.01 Million Stake in CME Group Inc. (NASDAQ:CME)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 14.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 68,955 shares of the financial services provider's stock after purchasing an additional 8,876 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in CME Group were worth $16,013,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares during the period. New Age Alpha Advisors LLC increased its position in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Financial Life Planners bought a new position in shares of CME Group in the fourth quarter worth $32,000. Knuff & Co LLC bought a new position in shares of CME Group in the fourth quarter worth $33,000. Finally, Banque Transatlantique SA bought a new position in shares of CME Group in the fourth quarter worth $35,000. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the transaction, the director now directly owns 3,668 shares in the company, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 28,384 shares of company stock valued at $7,531,053 over the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Trading Up 0.7%

Shares of NASDAQ:CME traded up $2.07 during midday trading on Friday, hitting $284.07. 2,323,467 shares of the stock were exchanged, compared to its average volume of 2,191,674. The stock has a market capitalization of $102.37 billion, a price-to-earnings ratio of 29.38, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The business's 50-day moving average price is $267.83 and its 200 day moving average price is $248.97. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The firm's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.50 earnings per share. Analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of recent analyst reports. UBS Group lifted their target price on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Bank of America lifted their target price on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Keefe, Bruyette & Woods lifted their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Barclays lifted their target price on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. decreased their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus target price of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.